Key Speakers

Radical Transformation of Life Sciences in Asia

Bio Investment Asia 2019 provides robust opportunities to network with the right partners. To attend the Bio Investment Asia, you will meet with international biotechnology firms and access to over 25 sessions, and networking opportunities with 9,000++ attendees from 30 countries. The event offers the business forum, conference sessions covering life sciences trends, policy & regulatory issues, research funding opportunities, startups, technology transfer, clinical trial and exhibition.

Mr. Joseph Damond
Executive Vice President, International Affairs, Biotechnology Innovation Organization (BIO), USA

Ms. Ruth Lee Choo Ai
Associate Director, Public Policy and Regulatory Affairs United States Pharmacopeia (USP)Singapore

Prof Matthew Bellgard
Chair, APEC LSIF Rare Disease Network; Director, eResearch, Queensland University of Technology (QUT), Australia

Mr. Mark Punyanitya
Co-Founder, President, CEO PhenoMx, Inc., USA

Dr. Agne Vaitkeviciene
Head of Research abd Development, Life Sciences, Verita Healthcare Group Ltd., Singapore

Mr. Adrián Gutiérrez
Head of Science & Technology Department at Embassy of Spain - CDTI´s Chief Representative for India and Southeast Asia

Mr. Akshat Kshetrapal
Director Rockstart Health Accelerator The Netherland

Prof. Alexander G Haslberger
Vienna University, Austria